iSense Corporation ("iSense") is a development stage company dedicated to the development and manufacture of a minimally-invasive continuous glucose monitor. Over the past thirteen years, iSense has built a portfolio of intellectual property through a combination of licensing agreements, partnerships and self-funded research. This has included the development of an advanced polymer membrane, a highly flexible miniature biosensor, and a unique automated manufacturing process.

Continuous monitoring will have a tremendous impact on the economics of diabetes healthcare; but economics aside, improved quality of life is enabled by the iSense CGM and this result is our foremost mission.

The devices described on this website are currently in clinical testing and not yet commercially available.